Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
EP-100
Also known as: formerly EP100
print preview
bookmark
share with colleague
General Information
Company
Esperance Pharmaceuticals Inc.
Description
Fusion protein consisting of a luteinizing hormone-releasing hormone (LHRH) ligand conjugated to a membrane-disrupting peptide
Molecular Target
Luteinizing hormone-releasing hormone (LHRH)
Mechanism of Action
Cell membrane integrity disruption
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Disease Category
Standard Indication
Indication Details
Partners
Milestones
Latest Stage of Development
More
Archive Items are loading
Set Email Alert
dummy